Endolymphatic hydrops revealed by magnetic resonance imaging in patients with atypical Meniere's disease

Acta Oto-Laryngologica

Volumn 133, Issue 2, 2013, Pages 123-129

  Kato, Masahiro ^a   Sugiura, Makoto ^a,b   Shimono, Mariko ^a   Yoshida, Tadao ^a   Otake, Hironao ^a   Kato, Ken ^a   Teranishi, Masaaki ^a   Sone, Michihiko ^a   Yamazaki, Masahiro ^a   Naganawa, Shinji ^a   Nakashima, Tsutomu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Toyota Kai Medical Corporation Kariya Toyota General Hospital   (Japan)

Author keywords

Cochlear Meniere's disease; Vestibular Meniere's disease

Indexed keywords

GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COCHLEAR MENIERE DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENDOLYMPHATIC SAC; FEMALE; HEARING IMPAIRMENT; HUMAN; INNER EAR DISEASE; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RECURRENT DISEASE; VERTIGO; VESTIBULAR DISORDER; VESTIBULAR MENIERE DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AUDIOMETRY, EVOKED RESPONSE; COCHLEA; DIAGNOSIS, DIFFERENTIAL; ENDOLYMPHATIC HYDROPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MENIERE DISEASE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; VESTIBULE, LABYRINTH; YOUNG ADULT;

EID: 84872357961     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2012.726374     Document Type: Article

References (21)

1. Alford BR. Report of subcommittee on equilibrium and its measurement. Meniere's disease: criteria for diagnosis and evaluation of therapy for reporting. Trans Am Acad Ophthalmol Otolaryngol 1972;76:1462-4.
2. Pearson BW, Brackmann DE. Committee on hearing and equilibrium guidelines for reporting treatment results in Meniere's disease. Otolaryngol Head Neck Surg 1985;93: 579-81.
3. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113: 181-5.
4. Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, et al. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007;117:415-20.
5. Nakashima T, Naganawa S, Teranishi M, Tagaya M, Nakata S, Sone M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière's disease. Acta Otolaryngol 2010;130:338-43.
6. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolymphatic hydrops in Ménière's disease with single-dose intravenous gadoliniumbased contrastmedia using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci 2010;9:237-42.
7. Nakashima T, Naganawa S, Katayama N, Teranishi M, Nakata S, Sugiura M, et al. Clinical significance of endolymphatic imaging after intratympanic gadolinium injection. Acta Otolaryngol Suppl 2009;129:9-14.
8. Naganawa S, Satake H, Iwano S, Fukatsu H, Sone M, Nakashima T. Imaging endolymphatic hydrops at 3 tesla using 3D-FLAIR with intratympanic Gd-DTPA administration. Magn Reson Med Sci 2008;7:85-91.
9. Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 tesla. Eur Radiol 2008;18:920-4.
10. Naganawa S, Kawai H, Sone M, Nakashima T. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010;9:73-80.
11. Nakashima T, Naganawa S, Pyykko I, Gibson W, Sone M, Nakata S, et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009; 129:5-8.
12. Sajjadi H, Paparella MM. Meniere's disease. Lancet 2008; 372:406-14.
13. Teranishi M, Naganawa S, Katayama N, Sugiura M, Nakata S, Sone M, et al. Image evaluation of endolymphatic space in fluctuating hearing loss without vertigo. Eur Arch Otorhinolaryngol 2009;266:1871-7.
14. Miyagawa M, Fukuoka H, Tsukada K, Oguchi T, Takumi Y, Sugiura M, et al. Endolymphatic hydrops and therapeutic effects are visualized in 'atypical' Meniere's disease. Acta Otolaryngol 2009;129:1326-9.
15. Wada T, Hara A, Takahashi K, Kusakari J, Yoshioka H, Niitsu M, et al. Evaluation of the vestibular aqueduct in vestibulocochlear disorders by magnetic resonance imaging. Acta Otolaryngol Suppl 2000;120:22-8.
16. Kitahara M, Takeda T, Yazawa Y, Matsubara H, Kitano H. Pathophysiology of Meniere's disease and its subvarieties. Acta Otolaryngol Suppl 1984;96:52-5.
17. Paparella MM, Mancini F. Vestibular Meniere's disease. Otolaryngol Head Neck Surg 1985;93:148-51.
18. Kohut RI, Lindsay JR. Pathologic changes in idiopathic labyrinthine hydrops. Correlations with previous findings. Acta Otolaryngol 1972;73:402-12.
19. Altmann F, Kornfeld M. Histological studies of Menière's disease. Ann Otol Rhinol Laryngol 1965;74: 915-43.
20. Paparella MM. Pathology of Meniere's disease. Ann Otol Rhinol Laryngol Suppl 1984;112:31-5.
21. Merchant SN, Adams JC, Nadol JB. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74-81.